-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical Network News on March 3
35 surgeries involved
A few days ago, the Tianjin Health Commission issued a notice on the "Restricted Clinical Application of Medical Technology Catalogue in Relevant Medical Institutions", announcing that a large number of medical institutions in Tianjin restricted clinical application of medical technology (list attached at the end of the article).
Including 35 items including cardiovascular disease intervention diagnosis and treatment technology, hemodialysis, neurovascular intervention diagnosis and treatment technology, artificial knee joint replacement technology, tumor ablation treatment technology and so on.
Including 35 items including cardiovascular disease intervention diagnosis and treatment technology, hemodialysis, neurovascular intervention diagnosis and treatment technology, artificial knee joint replacement technology, tumor ablation treatment technology and so on.
Restricted medical technology refers to medical technology that is safe and effective, but has high technical difficulties and high risks.
It has high requirements for the service ability and personnel technical level of medical institutions, and requires limited conditions.
It has high requirements for the service ability and personnel technical level of medical institutions, and requires limited conditions.
For example: Hematopoietic stem cell (including umbilical cord blood stem cell) transplantation to treat blood system diseases technology, tumor ablation treatment technology, respiratory endoscopy, digestive endoscopy, general surgery endoscopy, urology, arthroscopy, spinal endoscopy, thoracic surgery endoscopy , Gynecological Endoscopy, Rhinal Endoscopy, Throat Endoscopy, Pediatric Respiratory Endoscopy, Pediatric Gastroenterology Endoscopy, Pediatric Surgery Endoscopy diagnosis and treatment technology, artificial joint replacement technology (including knee, hip and other artificial joints), neurovascular intervention Diagnosis and treatment technology, interventional diagnosis and treatment technology for cardiovascular diseases, excimer laser corneal refractive surgery, etc.
Prior to this, the Shanghai Municipal Health Commission had also issued the "Regulations for the Implementation of Shanghai Municipal Measures for the Administration of Clinical Application of Medical Technology".
30 technologies including cardiovascular disease interventional diagnosis and treatment technology, artificial hip and knee joint replacement technology, neurovascular interventional diagnosis and treatment technology, etc.
are included in the "Shanghai Restricted Clinical Application Medical Technology Catalog.
"
30 technologies including cardiovascular disease interventional diagnosis and treatment technology, artificial hip and knee joint replacement technology, neurovascular interventional diagnosis and treatment technology, etc.
are included in the "Shanghai Restricted Clinical Application Medical Technology Catalog.
"
The main reason for the limitation is safety and effectiveness.
Taking the "Shanghai Implementation Regulations" as an example, medical technologies under one of the following circumstances are classified as "restricted technologies":
Taking the "Shanghai Implementation Regulations" as an example, medical technologies under one of the following circumstances are classified as "restricted technologies":
1.
The technical difficulty is high, the risk is high, and there are high professional requirements for the service ability and personnel level of medical institutions, and restrictive conditions need to be set;
The technical difficulty is high, the risk is high, and there are high professional requirements for the service ability and personnel level of medical institutions, and restrictive conditions need to be set;
2.
Need to consume scarce resources;
Need to consume scarce resources;
3.
Involving major ethical risks;
Involving major ethical risks;
4.
There are unreasonable clinical applications that require key management.
There are unreasonable clinical applications that require key management.
According to the "Shanghai Implementation Rules", Shanghai has established a dynamic management mechanism to dynamically evaluate and adjust the restricted technology catalogue based on actual conditions.
After the relevant technologies are listed in the catalog, strict management will be carried out.
The "Shanghai Implementation Rules" is applicable to all types of medical institutions and medical staff in Shanghai to carry out clinical applications of medical technologies.
After the relevant technologies are listed in the catalog, strict management will be carried out.
The "Shanghai Implementation Rules" is applicable to all types of medical institutions and medical staff in Shanghai to carry out clinical applications of medical technologies.
At the same time, the clinical application management norms of restricted technologies will be formulated and issued by the Municipal Health Commission or commissioned by professional organizations, and reported to the National Health Commission for the record.
Restriction is not the same as prohibition
For medical technologies that are not included in the catalog of prohibited technologies and restricted technologies, medical institutions may decide to carry out clinical applications based on their own functions, tasks, technical capabilities, etc.
, and shall implement strict management of the clinical applications of medical technologies.
, and shall implement strict management of the clinical applications of medical technologies.
Although some medical technologies are included in the restricted list and become restricted technologies, restriction does not mean prohibition.
In fact, the National Health Commission issued the "Administrative Measures for the Clinical Application of Medical Technology" in August 2018, which requires medical institutions to conduct self-assessment in accordance with relevant medical technology clinical application management practices, and those who meet the conditions can conduct clinical trials of restricted technologies.
application.
application.
However, if there is a clinical application of medical technology abolished or prohibited by the Ministry of Health in a medical institution, a new category 3 medical technology is used clinically without authorization, and the clinical application of medical technology has not been reviewed, the clinical application of medical technology is not reported to the health administration department.
In case of violating regulations but failing to immediately stop the clinical application of medical technology, failing to reapply for technical review according to regulations, or arbitrarily applying medical technology that needs to be reviewed for clinical application, the health administrative department shall immediately order it to make corrections.
In case of violating regulations but failing to immediately stop the clinical application of medical technology, failing to reapply for technical review according to regulations, or arbitrarily applying medical technology that needs to be reviewed for clinical application, the health administrative department shall immediately order it to make corrections.
If serious consequences are caused, the main person in charge and the person directly responsible for the medical institution shall be held accountable in accordance with the law.
The pharmnet.
com.
cn/news/yyzb/" target="_blank">purchase of consumables may drop
com.
cn/news/yyzb/" target="_blank">purchase of consumables may drop
After the list of restricted medical technologies is released, for the medical device industry, restricting the development of medical technologies means that related operations will be reduced, and the use of some equipment and consumables involved in operations will also be sharply reduced.
With the limitation of related medical technology, the purchase of consumables in the hospital is bound to be affected to a certain extent.
Take the interventional diagnosis and treatment technology of cardiovascular disease as an example.
The medical devices related to this medical technology include stents, catheters, guide wires, embolisms, puncture needles and many other high-value consumables.
The medical devices related to this medical technology include stents, catheters, guide wires, embolisms, puncture needles and many other high-value consumables.
In addition, after artificial replacement technology and various endoscopic diagnosis and treatment technologies are restricted, the use of related artificial hip joints, artificial knee joints, endoscopes, trocars, and other types of medical equipment in the hospital may directly decline.
Prior to this, the National Health and Medical Commission has explained the relevant situation of my country's medical services and medical quality and safety.
The country attaches special importance to the management of clinical applications of medical technology and has established a series of systems in the management of medical technology:
The country attaches special importance to the management of clinical applications of medical technology and has established a series of systems in the management of medical technology:
The first is the classification management system of medical technologies.
Those technologies that are not clinically safe and effective, have major ethical issues, have been eliminated clinically, and have not been demonstrated by clinical research, are classified as prohibited technologies.
As for technologies that are technically difficult, high-risk, and use scarce clinical resources, they are classified as restricted technologies.
Those technologies that are not clinically safe and effective, have major ethical issues, have been eliminated clinically, and have not been demonstrated by clinical research, are classified as prohibited technologies.
As for technologies that are technically difficult, high-risk, and use scarce clinical resources, they are classified as restricted technologies.
The second is to establish a filing system for restricted technologies.
For the 15 national-level restricted technologies that have been included in the list, clinical application and management specifications have been formulated.
Medical institutions that want to implement such technologies must evaluate the clinical application specifications of these clinical technologies.
The administrative department filed.
For the 15 national-level restricted technologies that have been included in the list, clinical application and management specifications have been formulated.
Medical institutions that want to implement such technologies must evaluate the clinical application specifications of these clinical technologies.
The administrative department filed.
The third is to establish a quality control system for medical technology.
For key medical technologies, there must be norms, quality control evaluation indicators, and quality control management through the quality control center.
For key medical technologies, there must be norms, quality control evaluation indicators, and quality control management through the quality control center.
The fourth is the standardized training system for the clinical application of medical technology.
Medical staff who implement key medical technologies must undergo standardized training to ensure the quality and safety of the clinical technology application process.
Medical staff who implement key medical technologies must undergo standardized training to ensure the quality and safety of the clinical technology application process.
The fifth is the information disclosure system.
Health administrative departments at or above the county level are required to disclose to the public in a timely manner the list of medical institutions that have been filed and can develop restricted medical technologies and related information to facilitate public inquiry and supervision.
Health administrative departments at or above the county level are required to disclose to the public in a timely manner the list of medical institutions that have been filed and can develop restricted medical technologies and related information to facilitate public inquiry and supervision.
Medical Network News on March 3
35 surgeries involved
A few days ago, the Tianjin Health Commission issued a notice on the "Restricted Clinical Application of Medical Technology Catalogue in Relevant Medical Institutions", announcing that a large number of medical institutions in Tianjin restricted clinical application of medical technology (list attached at the end of the article).
Including 35 items including cardiovascular disease intervention diagnosis and treatment technology, hemodialysis, neurovascular intervention diagnosis and treatment technology, artificial knee joint replacement technology, tumor ablation treatment technology and so on.
Including 35 items including cardiovascular disease intervention diagnosis and treatment technology, hemodialysis, neurovascular intervention diagnosis and treatment technology, artificial knee joint replacement technology, tumor ablation treatment technology and so on.
Restricted medical technology refers to medical technology that is safe and effective, but has high technical difficulties and high risks.
It has high requirements for the service ability and personnel technical level of medical institutions, and requires limited conditions.
It has high requirements for the service ability and personnel technical level of medical institutions, and requires limited conditions.
For example: Hematopoietic stem cell (including umbilical cord blood stem cell) transplantation to treat blood system diseases technology, tumor ablation treatment technology, respiratory endoscopy, digestive endoscopy, general surgery endoscopy, urology, arthroscopy, spinal endoscopy, thoracic surgery endoscopy , Gynecological Endoscopy, Rhinal Endoscopy, Throat Endoscopy, Pediatric Respiratory Endoscopy, Pediatric Gastroenterology Endoscopy, Pediatric Surgery Endoscopy diagnosis and treatment technology, artificial joint replacement technology (including knee, hip and other artificial joints), neurovascular intervention Diagnosis and treatment technology, interventional diagnosis and treatment technology for cardiovascular diseases, excimer laser corneal refractive surgery, etc.
Prior to this, the Shanghai Municipal Health Commission had also issued the "Regulations for the Implementation of Shanghai Municipal Measures for the Administration of Clinical Application of Medical Technology".
30 technologies including cardiovascular disease interventional diagnosis and treatment technology, artificial hip and knee joint replacement technology, neurovascular interventional diagnosis and treatment technology, etc.
are included in the "Shanghai Restricted Clinical Application Medical Technology Catalog.
"
30 technologies including cardiovascular disease interventional diagnosis and treatment technology, artificial hip and knee joint replacement technology, neurovascular interventional diagnosis and treatment technology, etc.
are included in the "Shanghai Restricted Clinical Application Medical Technology Catalog.
"
The main reason for the limitation is safety and effectiveness.
Taking the "Shanghai Implementation Regulations" as an example, medical technologies under one of the following circumstances are classified as "restricted technologies":
Taking the "Shanghai Implementation Regulations" as an example, medical technologies under one of the following circumstances are classified as "restricted technologies":
1.
The technical difficulty is high, the risk is high, and there are high professional requirements for the service ability and personnel level of medical institutions, and restrictive conditions need to be set;
The technical difficulty is high, the risk is high, and there are high professional requirements for the service ability and personnel level of medical institutions, and restrictive conditions need to be set;
2.
Need to consume scarce resources;
Need to consume scarce resources;
3.
Involving major ethical risks;
Involving major ethical risks;
4.
There are unreasonable clinical applications that require key management.
There are unreasonable clinical applications that require key management.
According to the "Shanghai Implementation Rules", Shanghai has established a dynamic management mechanism to dynamically evaluate and adjust the restricted technology catalogue based on actual conditions.
After the relevant technologies are listed in the catalog, strict management will be carried out.
The "Shanghai Implementation Rules" is applicable to all types of medical institutions and medical staff in Shanghai to carry out clinical applications of medical technologies.
After the relevant technologies are listed in the catalog, strict management will be carried out.
The "Shanghai Implementation Rules" is applicable to all types of medical institutions and medical staff in Shanghai to carry out clinical applications of medical technologies.
At the same time, the clinical application management norms of restricted technologies will be formulated and issued by the Municipal Health Commission or commissioned by professional organizations, and reported to the National Health Commission for the record.
Restriction is not the same as prohibition
For medical technologies that are not included in the catalog of prohibited technologies and restricted technologies, medical institutions may decide to carry out clinical applications based on their own functions, tasks, technical capabilities, etc.
, and shall implement strict management of the clinical applications of medical technologies.
, and shall implement strict management of the clinical applications of medical technologies.
Although some medical technologies are included in the restricted list and become restricted technologies, restriction does not mean prohibition.
In fact, the National Health Commission issued the "Administrative Measures for the Clinical Application of Medical Technology" in August 2018, which requires medical institutions to conduct self-assessment in accordance with relevant medical technology clinical application management practices, and those who meet the conditions can conduct clinical trials of restricted technologies.
application.
application.
However, if there is a clinical application of medical technology abolished or prohibited by the Ministry of Health in a medical institution, a new category 3 medical technology is used clinically without authorization, and the clinical application of medical technology has not been reviewed, the clinical application of medical technology is not reported to the health administration department.
In case of violating regulations but failing to immediately stop the clinical application of medical technology, failing to reapply for technical review according to regulations, or arbitrarily applying medical technology that needs to be reviewed for clinical application, the health administrative department shall immediately order it to make corrections.
In case of violating regulations but failing to immediately stop the clinical application of medical technology, failing to reapply for technical review according to regulations, or arbitrarily applying medical technology that needs to be reviewed for clinical application, the health administrative department shall immediately order it to make corrections.
If serious consequences are caused, the main person in charge and the person directly responsible for the medical institution shall be held accountable in accordance with the law.
The pharmnet.
com.
cn/news/yyzb/" target="_blank">purchase of consumables may drop
com.
cn/news/yyzb/" target="_blank">purchase of consumables may drop
After the list of restricted medical technologies is released, for the medical device industry, restricting the development of medical technologies means that related operations will be reduced, and the use of some equipment and consumables involved in operations will also be sharply reduced.
With the limitation of related medical technology, the purchase of consumables in the hospital is bound to be affected to a certain extent.
Take the interventional diagnosis and treatment technology of cardiovascular disease as an example.
The medical devices related to this medical technology include stents, catheters, guide wires, embolisms, puncture needles and many other high-value consumables.
The medical devices related to this medical technology include stents, catheters, guide wires, embolisms, puncture needles and many other high-value consumables.
In addition, after artificial replacement technology and various endoscopic diagnosis and treatment technologies are restricted, the use of related artificial hip joints, artificial knee joints, endoscopes, trocars, and other types of medical equipment in the hospital may directly decline.
Prior to this, the National Health and Medical Commission has explained the relevant situation of my country's medical services and medical quality and safety.
The country attaches special importance to the management of clinical applications of medical technology and has established a series of systems in the management of medical technology:
The country attaches special importance to the management of clinical applications of medical technology and has established a series of systems in the management of medical technology:
The first is the classification management system of medical technologies.
Those technologies that are not clinically safe and effective, have major ethical issues, have been eliminated clinically, and have not been demonstrated by clinical research, are classified as prohibited technologies.
As for technologies that are technically difficult, high-risk, and use scarce clinical resources, they are classified as restricted technologies.
Those technologies that are not clinically safe and effective, have major ethical issues, have been eliminated clinically, and have not been demonstrated by clinical research, are classified as prohibited technologies.
As for technologies that are technically difficult, high-risk, and use scarce clinical resources, they are classified as restricted technologies.
The second is to establish a filing system for restricted technologies.
For the 15 national-level restricted technologies that have been included in the list, clinical application and management specifications have been formulated.
Medical institutions that want to implement such technologies must evaluate the clinical application specifications of these clinical technologies.
The administrative department filed.
For the 15 national-level restricted technologies that have been included in the list, clinical application and management specifications have been formulated.
Medical institutions that want to implement such technologies must evaluate the clinical application specifications of these clinical technologies.
The administrative department filed.
The third is to establish a quality control system for medical technology.
For key medical technologies, there must be norms, quality control evaluation indicators, and quality control management through the quality control center.
For key medical technologies, there must be norms, quality control evaluation indicators, and quality control management through the quality control center.
The fourth is the standardized training system for the clinical application of medical technology.
Medical staff who implement key medical technologies must undergo standardized training to ensure the quality and safety of the clinical technology application process.
Medical staff who implement key medical technologies must undergo standardized training to ensure the quality and safety of the clinical technology application process.
The fifth is the information disclosure system.
Health administrative departments at or above the county level are required to disclose to the public in a timely manner the list of medical institutions that have been filed and can develop restricted medical technologies and related information to facilitate public inquiry and supervision.
Health administrative departments at or above the county level are required to disclose to the public in a timely manner the list of medical institutions that have been filed and can develop restricted medical technologies and related information to facilitate public inquiry and supervision.
Medical Network News on March 3
35 surgeries involved
35 surgeries involved A few days ago, the Tianjin Health Commission issued a notice on the "Restricted Clinical Application of Medical Technology Catalogue in Relevant Medical Institutions", announcing that a large number of medical institutions in Tianjin restricted clinical application of medical technology (list attached at the end of the article).
Including 35 items including cardiovascular disease intervention diagnosis and treatment technology, hemodialysis, neurovascular intervention diagnosis and treatment technology, artificial knee joint replacement technology, tumor ablation treatment technology and so on.
Tumor tumor tumorIncluding 35 items including cardiovascular disease intervention diagnosis and treatment technology, hemodialysis, neurovascular intervention diagnosis and treatment technology, artificial knee joint replacement technology, tumor ablation treatment technology and so on.
Restricted medical technology refers to medical technology that is safe and effective, but has high technical difficulties and high risks.
It has high requirements for the service ability and personnel technical level of medical institutions, and requires limited conditions.
It has high requirements for the service ability and personnel technical level of medical institutions, and requires limited conditions.
For example: Hematopoietic stem cell (including umbilical cord blood stem cell) transplantation to treat blood system diseases technology, tumor ablation treatment technology, respiratory endoscopy, digestive endoscopy, general surgery endoscopy, urology, arthroscopy, spinal endoscopy, thoracic surgery endoscopy , Gynecological Endoscopy, Rhinal Endoscopy, Throat Endoscopy, Pediatric Respiratory Endoscopy, Pediatric Gastroenterology Endoscopy, Pediatric Surgery Endoscopy diagnosis and treatment technology, artificial joint replacement technology (including knee, hip and other artificial joints), neurovascular intervention Diagnosis and treatment technology, interventional diagnosis and treatment technology for cardiovascular diseases, excimer laser corneal refractive surgery, etc.
Prior to this, the Shanghai Municipal Health Commission had also issued the "Regulations for the Implementation of Shanghai Municipal Measures for the Administration of Clinical Application of Medical Technology".
30 technologies including cardiovascular disease interventional diagnosis and treatment technology, artificial hip and knee joint replacement technology, neurovascular interventional diagnosis and treatment technology, etc.
are included in the "Shanghai Restricted Clinical Application Medical Technology Catalog.
"
30 technologies including cardiovascular disease interventional diagnosis and treatment technology, artificial hip and knee joint replacement technology, neurovascular interventional diagnosis and treatment technology, etc.
are included in the "Shanghai Restricted Clinical Application Medical Technology Catalog.
"
The main reason for the limitation is safety and effectiveness.
Taking the "Shanghai Implementation Regulations" as an example, medical technologies under one of the following circumstances are classified as "restricted technologies":
Taking the "Shanghai Implementation Regulations" as an example, medical technologies under one of the following circumstances are classified as "restricted technologies":
1.
The technical difficulty is high, the risk is high, and there are high professional requirements for the service ability and personnel level of medical institutions, and restrictive conditions need to be set;
The technical difficulty is high, the risk is high, and there are high professional requirements for the service ability and personnel level of medical institutions, and restrictive conditions need to be set;
2.
Need to consume scarce resources;
Need to consume scarce resources;
3.
Involving major ethical risks;
Involving major ethical risks;
4.
There are unreasonable clinical applications that require key management.
There are unreasonable clinical applications that require key management.
According to the "Shanghai Implementation Rules", Shanghai has established a dynamic management mechanism to dynamically evaluate and adjust the restricted technology catalogue based on actual conditions.
After the relevant technologies are listed in the catalog, strict management will be carried out.
The "Shanghai Implementation Rules" is applicable to all types of medical institutions and medical staff in Shanghai to carry out clinical applications of medical technologies.
After the relevant technologies are listed in the catalog, strict management will be carried out.
The "Shanghai Implementation Rules" is applicable to all types of medical institutions and medical staff in Shanghai to carry out clinical applications of medical technologies.
At the same time, the clinical application management norms of restricted technologies will be formulated and issued by the Municipal Health Commission or commissioned by professional organizations, and reported to the National Health Commission for the record.
Restriction is not the same as prohibition
Restriction is not the same as prohibition For medical technologies that are not included in the catalog of prohibited technologies and restricted technologies, medical institutions may decide to carry out clinical applications based on their own functions, tasks, technical capabilities, etc.
, and shall implement strict management of the clinical applications of medical technologies.
, and shall implement strict management of the clinical applications of medical technologies.
Although some medical technologies are included in the restricted list and become restricted technologies, restriction does not mean prohibition.
In fact, the National Health Commission issued the "Administrative Measures for the Clinical Application of Medical Technology" in August 2018, which requires medical institutions to conduct self-assessment in accordance with relevant medical technology clinical application management practices, and those who meet the conditions can conduct clinical trials of restricted technologies.
application.
application.
However, if there is a clinical application of medical technology abolished or prohibited by the Ministry of Health in a medical institution, a new category 3 medical technology is used clinically without authorization, and the clinical application of medical technology has not been reviewed, the clinical application of medical technology is not reported to the health administration department.
In case of violating regulations but failing to immediately stop the clinical application of medical technology, failing to reapply for technical review according to regulations, or arbitrarily applying medical technology that needs to be reviewed for clinical application, the health administrative department shall immediately order it to make corrections.
In case of violating regulations but failing to immediately stop the clinical application of medical technology, failing to reapply for technical review according to regulations, or arbitrarily applying medical technology that needs to be reviewed for clinical application, the health administrative department shall immediately order it to make corrections.
If serious consequences are caused, the main person in charge and the person directly responsible for the medical institution shall be held accountable in accordance with the law.
The pharmnet.
com.
cn/news/yyzb/" target="_blank">purchase of consumables may drop
Supplies pharmnet. com.
cn/news/yyzb/" target="_blank">purchase of consumables may drop
com.
cn/news/yyzb/" target="_blank">Purchasepharmnet.
com.
cn/news/yyzb/" target="_blank"> purchase purchase amount or to decline
After the list of restricted medical technologies is released, for the medical device industry, restricting the development of medical technologies means that related operations will be reduced, and the use of some equipment and consumables involved in operations will also be sharply reduced.
Medical equipment medical equipment medical equipment With the limitation of related medical technology, the purchase of consumables in the hospital is bound to be affected to a certain extent.
Take the interventional diagnosis and treatment technology of cardiovascular disease as an example.
The medical devices related to this medical technology include stents, catheters, guide wires, embolisms, puncture needles and many other high-value consumables.
Disease disease diseaseThe medical devices related to this medical technology include stents, catheters, guide wires, embolisms, puncture needles and many other high-value consumables.
In addition, after artificial replacement technology and various endoscopic diagnosis and treatment technologies are restricted, the use of related artificial hip joints, artificial knee joints, endoscopes, trocars, and other types of medical equipment in the hospital may directly decline.
Prior to this, the National Health and Medical Commission has explained the relevant situation of my country's medical services and medical quality and safety.
The country attaches special importance to the management of clinical applications of medical technology and has established a series of systems in the management of medical technology:
The country attaches special importance to the management of clinical applications of medical technology and has established a series of systems in the management of medical technology:
The first is the classification management system of medical technologies.
Those technologies that are not clinically safe and effective, have major ethical issues, have been eliminated clinically, and have not been demonstrated by clinical research, are classified as prohibited technologies.
As for technologies that are technically difficult, high-risk, and use scarce clinical resources, they are classified as restricted technologies.
Those technologies that are not clinically safe and effective, have major ethical issues, have been eliminated clinically, and have not been demonstrated by clinical research, are classified as prohibited technologies.
As for technologies that are technically difficult, high-risk, and use scarce clinical resources, they are classified as restricted technologies.
The second is to establish a filing system for restricted technologies.
For the 15 national-level restricted technologies that have been included in the list, clinical application and management specifications have been formulated.
Medical institutions that want to implement such technologies must evaluate the clinical application specifications of these clinical technologies.
The administrative department filed.
For the 15 national-level restricted technologies that have been included in the list, clinical application and management specifications have been formulated.
Medical institutions that want to implement such technologies must evaluate the clinical application specifications of these clinical technologies.
The administrative department filed.
The third is to establish a quality control system for medical technology.
For key medical technologies, there must be norms, quality control evaluation indicators, and quality control management through the quality control center.
For key medical technologies, there must be norms, quality control evaluation indicators, and quality control management through the quality control center.
The fourth is the standardized training system for the clinical application of medical technology.
Medical staff who implement key medical technologies must undergo standardized training to ensure the quality and safety of the clinical technology application process.
Medical staff who implement key medical technologies must undergo standardized training to ensure the quality and safety of the clinical technology application process.
The fifth is the information disclosure system.
Health administrative departments at or above the county level are required to disclose to the public in a timely manner the list of medical institutions that have been filed and can develop restricted medical technologies and related information to facilitate public inquiry and supervision.
Healthy, healthy, healthyHealth administrative departments at or above the county level are required to disclose to the public in a timely manner the list of medical institutions that have been filed and can develop restricted medical technologies and related information to facilitate public inquiry and supervision.
